MOGAM Institute for Biomedical Research

MOGAM Institute for Biomedical Research (MIBR) is a biopharma and biotechnology company based in South Korea. Since its establishment in 1984, MIBR has been dedicated to advancing global health by focusing on the development of treatments and vaccines for a wide range of conditions including rare diseases, autoimmune disorders, infectious diseases, and cancers. The company's slogan "Advancing global health with AI-driven therapies for rare diseases, autoimmune disorders, infections, and cancers" reflects its commitment to leveraging artificial intelligence for novel drug development and creating new therapeutic solutions. While specific details about its latest investment and investors are not available, MIBR's focus on leveraging AI for drug development positions it as an intriguing prospect for investors looking to contribute to the advancement of global public health through innovative biomedical research.